Here is a list of medical research studies that we have completed over the years:
1.- A Phase III, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of the Xaracoll Bupivicaine implant (300mg Bupivicaine Hydrochloride) after open laparotomy hernioplasty.
Completed: June 2016
2.- A randomized, double-blind, multicenter, superiority, placebo-controlled, phase 3 study of Pexiganan Cream 0.8%, applied twice daily for 14 days in the treatment of adults with mild infections of diabetic foot ulcers.
Completed: August 2016
3.- A Phase 3, randomized, double-blind study comparing ABT-494 once daily monotherapy to methotrexate (MTX) monotherapy in MTX- Naïve subjects with moderately to severely active rheumatoid arthritis.
Completed: October 2017
4.- A phase 3, randomized, double-blind study comparing ABT-494 to placebo and to Adalimumab in subjects with moderately to severely active rheumatoid arthritis who are on a stable background of methotrexate (MTX) and who have an inadequate response to MTX (MTX-IR).
5.- A multicenter, randomized, double-blind, crossover study to assess the injection site pain associated with a modified etanercept formulation in adult subjects with either rheumatoid arthritis or psoriatic arthritis.
Completed: November 2017
6.- A randomized, double-blind, double-dummy, multicenter, active-controlled study to evaluate the efficacy and safety of Vedolizumab IV compared to Adalimumab SC in subjects with ulcerative colitis.
Completed: January 2018
7.- Randomized, double-blind, multicenter, 3-stage, efficacy and safety study of NI-071 and US licensed Remicade® (Infliximab) for the treatment 2f patients with rheumatoid arthritis.
Completed: March 2018
8.- A phase III, double-blind, randomized, long-term, placebo-controlled, multicenter, study evaluating the safety and efficacy of Obeticholic Acid in subjects with non-alcoholic steatohepatitis.
Completed: July 2018
9.- A phase III, randomized, open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer®) and iron sucrose in subjects with iron deficiency anemia and non-dialysis-dependent chronic kidney disease.
Completed: September 2018
10.- A randomized, double-blind, placebo-controlled, parallel group study of Patiromer for the enablement of spironolactone use for blood pressure control in patients with resistant hypertension and chronic kidney disease: Evaluation of safety and efficacy (AMBER)
Completed: March 2019
11.- A randomized parallel-group, placebo-controlled, double-blind, multi-center trial to evaluate the efficacy and safety of the oral sGC stimulator vericiguat to improve physical functioning in activities of daily living in patients with heart failure and preserved ejection fraction (VITALITY-HFpEF).
Completed: April 2019
12.- Evaluation of the performance of the clinical genomics colvera test in the detention of disease recurrence in patients diagnosed with colorectal cancer.
Completed: August 2019
13.- A randomized, controlled double-blind study comparing the efficacy and safety of Orelvo (voclosporin) (23.7mg twice daily) with placebo in achieving renal response in subjects with active lupus nephritis.
Completed: January 2020
14.- Phase III, double-blind, randomized, placebo controlled, multicenter, and study to assess the safety and efficacy of vm202 to treat chronic nonhealing foot ulcers in diabetic patients with concomitant peripheral arterial disease (PAD).
Completed: January 2020